Attention Deficit Hyperactivity Disorder. Hyperkinetic disorders
Conditions
Interventions
Intervention 1: Methylphenidate(tab 10 mg) was started at a dose of 2.5 mg per day and gradually (every week) increased based on the therapeutic response and the patient’s tolerance. The optimal dose
Treatment - Drugs
Methylphenidate(tab 10 mg) was started at a dose of 2.5 mg per day and gradually (every week) increased based on the therapeutic response and the patient’s tolerance. The optimal dose of methylphenida
Risperidone was started at dose of 0.25 mg per day and increased 0.5 mg/d in the first 2 weeks (in 2 divided doses), then gradually (every two weeks) increased based on the therapeutic response and to
Sponsors
Behavioral Sciences Research Center, Shaheed Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 6 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 3-6 years, presence of ADHD rating scale score more than 20 at the baseline Exclusion criteria: presence of any physical disease, any comorbid psychiatric disorders (for example: mood disorders, anxiety disorders, tic disorders, pervasive developmental disorders), mental retardation (IQ < 70), receiving any drug or other treatment over 2 month prior to the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ADHD ratinig scale- parent. Timepoint: every 2 weeks: at the baseline, week 2, week 4, and week 6. Method of measurement: ADHD rating scale score.;Conners' Rating Scale-parent. Timepoint: every 2 weeks: at the baseline, week 2, week 4, and week 6. Method of measurement: Conners' Rating Scale score. | — |
Secondary
| Measure | Time frame |
|---|---|
| Side effects. Timepoint: every 2 weeks:every 2 weeks: week 2 (T1), week 4 (T2) and week 4 (T3). Method of measurement: intensity and frequency of side effects by using questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFariba Arabgol
Shaheed Beheshti University of Medical Sciences
Outcome results
None listed